scholarly journals Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　– ODYSSEY JAPAN Randomized Controlled Trial –

2016 ◽  
Vol 80 (9) ◽  
pp. 1980-1987 ◽  
Author(s):  
Tamio Teramoto ◽  
Masahiko Kobayashi ◽  
Hiromi Tasaki ◽  
Hiroaki Yagyu ◽  
Toshinori Higashikata ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cardiovascular Risk ◽  
Familial Hypercholesterolemia ◽  
Controlled Trial ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
High Cardiovascular Risk ◽  
Randomized Controlled ◽  
Heterozygous Familial Hypercholesterolemia

Improved health outcomes by indentifying high cardiovascular risk individuals in a pharmacy setting – A randomized controlled trial

2015 ◽  
Vol 241 (1) ◽  
pp. e128-e129
Author(s):  
K. Svendsen ◽  
V. Telle-Hansen ◽  
K. Wilhelmsen Garstad ◽  
L.T. Mørch-Reiersen ◽  
D.R. Jacobs ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cardiovascular Risk ◽  
Health Outcomes ◽  
Controlled Trial ◽  
High Cardiovascular Risk ◽  
Randomized Controlled ◽  
Pharmacy Setting

scholarly journals Effects of exergaming in postmenopausal women with high cardiovascular risk: A randomized controlled trial

2019 ◽  
Vol 43 (4) ◽  
pp. 363-370 ◽  
Author(s):  
Eun‐Ah Jo ◽  
Shan‐Shan Wu ◽  
Hyung‐Rae Han ◽  
Jung‐Jun Park ◽  
Saejong Park ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Cardiovascular Risk ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
High Cardiovascular Risk ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document